nodes	percent_of_prediction	percent_of_DWPC	metapath
Yohimbine—CYP3A4—Imiquimod—skin cancer	0.183	0.233	CbGbCtD
Yohimbine—CYP3A4—Temozolomide—skin cancer	0.183	0.233	CbGbCtD
Yohimbine—CYP2D6—Vemurafenib—skin cancer	0.158	0.201	CbGbCtD
Yohimbine—CYP3A4—Vismodegib—skin cancer	0.127	0.162	CbGbCtD
Yohimbine—CYP3A4—Vemurafenib—skin cancer	0.1	0.128	CbGbCtD
Yohimbine—CYP3A4—Docetaxel—skin cancer	0.0345	0.0438	CbGbCtD
Yohimbine—HTR2A—hindlimb—skin cancer	0.00609	0.0546	CbGeAlD
Yohimbine—HTR1B—blood vessel—skin cancer	0.00604	0.0542	CbGeAlD
Yohimbine—HTR1D—blood vessel—skin cancer	0.00585	0.0525	CbGeAlD
Yohimbine—DRD2—nerve—skin cancer	0.00561	0.0503	CbGeAlD
Yohimbine—HTR2A—appendage—skin cancer	0.00522	0.0468	CbGeAlD
Yohimbine—HTR1F—head—skin cancer	0.00446	0.04	CbGeAlD
Yohimbine—ADRA1D—epithelium—skin cancer	0.00381	0.0342	CbGeAlD
Yohimbine—HTR2A—nerve—skin cancer	0.0037	0.0332	CbGeAlD
Yohimbine—HTR2A—endothelium—skin cancer	0.00315	0.0283	CbGeAlD
Yohimbine—DRD3—head—skin cancer	0.00315	0.0282	CbGeAlD
Yohimbine—ADRA2C—nipple—skin cancer	0.0031	0.0278	CbGeAlD
Yohimbine—HTR1D—connective tissue—skin cancer	0.003	0.0269	CbGeAlD
Yohimbine—HTR2A—blood vessel—skin cancer	0.00291	0.0261	CbGeAlD
Yohimbine—ADRA1D—female reproductive system—skin cancer	0.00283	0.0254	CbGeAlD
Yohimbine—HTR2B—skin of body—skin cancer	0.00252	0.0226	CbGeAlD
Yohimbine—ADRA2A—nipple—skin cancer	0.00247	0.0222	CbGeAlD
Yohimbine—ADRA1B—head—skin cancer	0.00242	0.0217	CbGeAlD
Yohimbine—ADRA1D—head—skin cancer	0.00236	0.0212	CbGeAlD
Yohimbine—HTR1B—female reproductive system—skin cancer	0.00219	0.0196	CbGeAlD
Yohimbine—HTR1D—female reproductive system—skin cancer	0.00212	0.019	CbGeAlD
Yohimbine—HTR2C—female reproductive system—skin cancer	0.0021	0.0188	CbGeAlD
Yohimbine—HTR2A—neck—skin cancer	0.00208	0.0187	CbGeAlD
Yohimbine—SLC6A4—female reproductive system—skin cancer	0.00199	0.0178	CbGeAlD
Yohimbine—HTR2B—female reproductive system—skin cancer	0.00197	0.0177	CbGeAlD
Yohimbine—HTR1B—head—skin cancer	0.00183	0.0164	CbGeAlD
Yohimbine—ADRA2C—mammalian vulva—skin cancer	0.00181	0.0162	CbGeAlD
Yohimbine—HTR1D—head—skin cancer	0.00177	0.0159	CbGeAlD
Yohimbine—ADRA2A—connective tissue—skin cancer	0.00175	0.0157	CbGeAlD
Yohimbine—HTR2C—head—skin cancer	0.00175	0.0157	CbGeAlD
Yohimbine—SLC6A4—head—skin cancer	0.00166	0.0149	CbGeAlD
Yohimbine—HTR2B—head—skin cancer	0.00164	0.0147	CbGeAlD
Yohimbine—HTR2A—connective tissue—skin cancer	0.00149	0.0134	CbGeAlD
Yohimbine—HTR1A—head—skin cancer	0.00147	0.0132	CbGeAlD
Yohimbine—ADRA2A—mammalian vulva—skin cancer	0.00144	0.0129	CbGeAlD
Yohimbine—HTR2A—epithelium—skin cancer	0.00141	0.0127	CbGeAlD
Yohimbine—DRD2—head—skin cancer	0.00133	0.0119	CbGeAlD
Yohimbine—ADRA2C—head—skin cancer	0.00129	0.0116	CbGeAlD
Yohimbine—ADRA2A—female reproductive system—skin cancer	0.00124	0.0111	CbGeAlD
Yohimbine—HTR2B—lymph node—skin cancer	0.00115	0.0103	CbGeAlD
Yohimbine—HTR2A—female reproductive system—skin cancer	0.00105	0.00943	CbGeAlD
Yohimbine—ADRA2A—head—skin cancer	0.00103	0.00926	CbGeAlD
Yohimbine—CYP3A4—female reproductive system—skin cancer	0.000973	0.00873	CbGeAlD
Yohimbine—CYP2D6—female reproductive system—skin cancer	0.000957	0.00859	CbGeAlD
Yohimbine—ADRA2C—lymph node—skin cancer	0.000906	0.00813	CbGeAlD
Yohimbine—HTR2A—head—skin cancer	0.000878	0.00788	CbGeAlD
Yohimbine—CYP2D6—head—skin cancer	0.0008	0.00718	CbGeAlD
Yohimbine—ADRA2A—lymph node—skin cancer	0.000723	0.00649	CbGeAlD
Yohimbine—HTR2A—Signaling Pathways—SUFU—skin cancer	7.11e-05	0.000695	CbGpPWpGaD
Yohimbine—DRD2—Circadian rythm related genes—TP53—skin cancer	7.05e-05	0.000689	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—PLIN2—skin cancer	7.01e-05	0.000686	CbGpPWpGaD
Yohimbine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	6.93e-05	0.000677	CbGpPWpGaD
Yohimbine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	6.93e-05	0.000677	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—MC1R—skin cancer	6.92e-05	0.000677	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—FOXO4—skin cancer	6.86e-05	0.00067	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—PTCH1—skin cancer	6.82e-05	0.000667	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—SMO—skin cancer	6.82e-05	0.000667	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—SMO—skin cancer	6.82e-05	0.000667	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—PTCH1—skin cancer	6.82e-05	0.000667	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—GLI1—skin cancer	6.82e-05	0.000667	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—FOXO4—skin cancer	6.71e-05	0.000656	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—PTGER4—skin cancer	6.64e-05	0.00065	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—PTGER4—skin cancer	6.64e-05	0.00065	CbGpPWpGaD
Yohimbine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	6.63e-05	0.000648	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—SHH—skin cancer	6.5e-05	0.000635	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—SUFU—skin cancer	6.46e-05	0.000632	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—RASA1—skin cancer	6.46e-05	0.000631	CbGpPWpGaD
Yohimbine—DRD2—Circadian rythm related genes—IL6—skin cancer	6.45e-05	0.000631	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—FOXO4—skin cancer	6.31e-05	0.000617	CbGpPWpGaD
Yohimbine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	6.28e-05	0.000615	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—SHH—skin cancer	6.27e-05	0.000613	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—SHH—skin cancer	6.24e-05	0.00061	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—RASA1—skin cancer	6.23e-05	0.00061	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—RASA1—skin cancer	6.2e-05	0.000606	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—SMO—skin cancer	6.16e-05	0.000602	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—PTCH1—skin cancer	6.16e-05	0.000602	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—SHH—skin cancer	6.07e-05	0.000594	CbGpPWpGaD
Yohimbine—HTR1F—Signaling by GPCR—NRAS—skin cancer	6.03e-05	0.00059	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—RASA1—skin cancer	6.03e-05	0.00059	CbGpPWpGaD
Yohimbine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	6.02e-05	0.000588	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—PTGER4—skin cancer	6e-05	0.000586	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—SHH—skin cancer	5.97e-05	0.000584	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—PTCH1—skin cancer	5.95e-05	0.000581	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—SMO—skin cancer	5.95e-05	0.000581	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—RASA1—skin cancer	5.94e-05	0.00058	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—PTCH1—skin cancer	5.92e-05	0.000578	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—SMO—skin cancer	5.92e-05	0.000578	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—ENO2—skin cancer	5.9e-05	0.000577	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—FOXO4—skin cancer	5.87e-05	0.000574	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—FOXO4—skin cancer	5.87e-05	0.000574	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—PTGER4—skin cancer	5.79e-05	0.000566	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—PTGER4—skin cancer	5.76e-05	0.000563	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—PTCH1—skin cancer	5.75e-05	0.000563	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—SMO—skin cancer	5.75e-05	0.000563	CbGpPWpGaD
Yohimbine—HTR1F—Signaling Pathways—BRAF—skin cancer	5.67e-05	0.000554	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—SMO—skin cancer	5.66e-05	0.000554	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—PTCH1—skin cancer	5.66e-05	0.000554	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—CSPG4—skin cancer	5.65e-05	0.000553	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—PTGER4—skin cancer	5.6e-05	0.000548	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—PTGER4—skin cancer	5.51e-05	0.000539	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—SHH—skin cancer	5.51e-05	0.000539	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—RASA1—skin cancer	5.47e-05	0.000535	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—SHH—skin cancer	5.42e-05	0.00053	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—RASA1—skin cancer	5.38e-05	0.000527	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—FOXO4—skin cancer	5.3e-05	0.000518	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—PTCH1—skin cancer	5.22e-05	0.000511	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—SMO—skin cancer	5.22e-05	0.000511	CbGpPWpGaD
Yohimbine—ADRA2B—Hemostasis—NRAS—skin cancer	5.19e-05	0.000508	CbGpPWpGaD
Yohimbine—HTR1F—Signaling by GPCR—KRAS—skin cancer	5.19e-05	0.000508	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—SMO—skin cancer	5.14e-05	0.000502	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—PTCH1—skin cancer	5.14e-05	0.000502	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—FOXO4—skin cancer	5.11e-05	0.0005	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—FOXO4—skin cancer	5.09e-05	0.000497	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—PTGER4—skin cancer	5.08e-05	0.000497	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—PTGER4—skin cancer	5e-05	0.000489	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—FOXO4—skin cancer	4.95e-05	0.000484	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—SHH—skin cancer	4.93e-05	0.000482	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—RASA1—skin cancer	4.9e-05	0.000479	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—FOXO4—skin cancer	4.87e-05	0.000476	CbGpPWpGaD
Yohimbine—ADRA2C—Hemostasis—NRAS—skin cancer	4.85e-05	0.000474	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—SMO—skin cancer	4.67e-05	0.000457	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—PTCH1—skin cancer	4.67e-05	0.000457	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—PLIN2—skin cancer	4.58e-05	0.000448	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—TERT—skin cancer	4.58e-05	0.000448	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—PTGER4—skin cancer	4.55e-05	0.000445	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—FOXO4—skin cancer	4.49e-05	0.000439	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—TERT—skin cancer	4.48e-05	0.000438	CbGpPWpGaD
Yohimbine—ADRA2B—Hemostasis—KRAS—skin cancer	4.47e-05	0.000437	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—FOXO4—skin cancer	4.42e-05	0.000432	CbGpPWpGaD
Yohimbine—HTR1F—Signaling by GPCR—HRAS—skin cancer	4.41e-05	0.000432	CbGpPWpGaD
Yohimbine—HTR1F—Signaling by GPCR—IL6—skin cancer	4.22e-05	0.000413	CbGpPWpGaD
Yohimbine—ADRA2C—Metabolism—ERCC2—skin cancer	4.22e-05	0.000412	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—TERT—skin cancer	4.21e-05	0.000412	CbGpPWpGaD
Yohimbine—ADRA2C—Hemostasis—KRAS—skin cancer	4.18e-05	0.000408	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—FOXO4—skin cancer	4.02e-05	0.000393	CbGpPWpGaD
Yohimbine—ADRA2B—Hemostasis—TP53—skin cancer	3.97e-05	0.000389	CbGpPWpGaD
Yohimbine—ADRA2A—Hemostasis—NRAS—skin cancer	3.94e-05	0.000385	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—TERT—skin cancer	3.92e-05	0.000383	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—TERT—skin cancer	3.92e-05	0.000383	CbGpPWpGaD
Yohimbine—HTR1D—Signaling by GPCR—NRAS—skin cancer	3.86e-05	0.000377	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—ENO2—skin cancer	3.84e-05	0.000376	CbGpPWpGaD
Yohimbine—ADRA2B—Hemostasis—HRAS—skin cancer	3.8e-05	0.000372	CbGpPWpGaD
Yohimbine—HTR1B—Signaling by GPCR—NRAS—skin cancer	3.78e-05	0.000369	CbGpPWpGaD
Yohimbine—ADRA2C—Hemostasis—TP53—skin cancer	3.71e-05	0.000363	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—CSPG4—skin cancer	3.7e-05	0.000361	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—BRAF—skin cancer	3.63e-05	0.000355	CbGpPWpGaD
Yohimbine—HTR1F—Signaling Pathways—NRAS—skin cancer	3.56e-05	0.000348	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—BRAF—skin cancer	3.55e-05	0.000347	CbGpPWpGaD
Yohimbine—ADRA2C—Hemostasis—HRAS—skin cancer	3.55e-05	0.000347	CbGpPWpGaD
Yohimbine—HTR2B—Signaling by GPCR—NRAS—skin cancer	3.55e-05	0.000347	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—TERT—skin cancer	3.54e-05	0.000346	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—ERCC2—skin cancer	3.42e-05	0.000335	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—TERT—skin cancer	3.42e-05	0.000334	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—TERT—skin cancer	3.4e-05	0.000332	CbGpPWpGaD
Yohimbine—ADRA2A—Hemostasis—KRAS—skin cancer	3.39e-05	0.000332	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—BRAF—skin cancer	3.34e-05	0.000326	CbGpPWpGaD
Yohimbine—HTR1D—Signaling by GPCR—KRAS—skin cancer	3.32e-05	0.000325	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—TERT—skin cancer	3.3e-05	0.000323	CbGpPWpGaD
Yohimbine—DRD3—Signaling by GPCR—NRAS—skin cancer	3.3e-05	0.000323	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling by GPCR—NRAS—skin cancer	3.3e-05	0.000323	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—TERT—skin cancer	3.25e-05	0.000318	CbGpPWpGaD
Yohimbine—HTR1B—Signaling by GPCR—KRAS—skin cancer	3.25e-05	0.000318	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—BRAF—skin cancer	3.1e-05	0.000303	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—BRAF—skin cancer	3.1e-05	0.000303	CbGpPWpGaD
Yohimbine—HTR1F—Signaling Pathways—KRAS—skin cancer	3.07e-05	0.0003	CbGpPWpGaD
Yohimbine—HTR2B—Signaling by GPCR—KRAS—skin cancer	3.05e-05	0.000299	CbGpPWpGaD
Yohimbine—ADRA2A—Hemostasis—TP53—skin cancer	3.01e-05	0.000295	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—TERT—skin cancer	3e-05	0.000293	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling by GPCR—NRAS—skin cancer	2.98e-05	0.000291	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—TERT—skin cancer	2.95e-05	0.000289	CbGpPWpGaD
Yohimbine—ADRA2A—Hemostasis—HRAS—skin cancer	2.88e-05	0.000282	CbGpPWpGaD
Yohimbine—HTR1A—Signaling by GPCR—NRAS—skin cancer	2.88e-05	0.000281	CbGpPWpGaD
Yohimbine—HTR2C—Signaling by GPCR—NRAS—skin cancer	2.86e-05	0.00028	CbGpPWpGaD
Yohimbine—DRD3—Signaling by GPCR—KRAS—skin cancer	2.84e-05	0.000278	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling by GPCR—KRAS—skin cancer	2.84e-05	0.000278	CbGpPWpGaD
Yohimbine—HTR1D—Signaling by GPCR—HRAS—skin cancer	2.82e-05	0.000276	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—BRAF—skin cancer	2.8e-05	0.000274	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling by GPCR—NRAS—skin cancer	2.78e-05	0.000272	CbGpPWpGaD
Yohimbine—HTR1B—Signaling by GPCR—HRAS—skin cancer	2.76e-05	0.00027	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling by GPCR—NRAS—skin cancer	2.74e-05	0.000268	CbGpPWpGaD
Yohimbine—HTR1F—Signaling Pathways—TP53—skin cancer	2.73e-05	0.000267	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—BRAF—skin cancer	2.7e-05	0.000264	CbGpPWpGaD
Yohimbine—HTR1D—Signaling by GPCR—IL6—skin cancer	2.7e-05	0.000264	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—BRAF—skin cancer	2.69e-05	0.000263	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—TERT—skin cancer	2.68e-05	0.000262	CbGpPWpGaD
Yohimbine—HTR1B—Signaling by GPCR—IL6—skin cancer	2.64e-05	0.000259	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—BRAF—skin cancer	2.62e-05	0.000256	CbGpPWpGaD
Yohimbine—HTR1F—Signaling Pathways—HRAS—skin cancer	2.61e-05	0.000255	CbGpPWpGaD
Yohimbine—HTR2B—Signaling by GPCR—HRAS—skin cancer	2.6e-05	0.000254	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—BRAF—skin cancer	2.58e-05	0.000252	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling by GPCR—KRAS—skin cancer	2.57e-05	0.000251	CbGpPWpGaD
Yohimbine—ADRA2C—Metabolism—PTGS2—skin cancer	2.53e-05	0.000247	CbGpPWpGaD
Yohimbine—DRD2—Signaling by GPCR—NRAS—skin cancer	2.53e-05	0.000247	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—ENO2—skin cancer	2.51e-05	0.000246	CbGpPWpGaD
Yohimbine—HTR1F—Signaling Pathways—IL6—skin cancer	2.5e-05	0.000244	CbGpPWpGaD
Yohimbine—HTR2A—Signaling by GPCR—NRAS—skin cancer	2.49e-05	0.000243	CbGpPWpGaD
Yohimbine—HTR2B—Signaling by GPCR—IL6—skin cancer	2.48e-05	0.000243	CbGpPWpGaD
Yohimbine—HTR1A—Signaling by GPCR—KRAS—skin cancer	2.48e-05	0.000242	CbGpPWpGaD
Yohimbine—HTR2C—Signaling by GPCR—KRAS—skin cancer	2.46e-05	0.000241	CbGpPWpGaD
Yohimbine—DRD3—Signaling by GPCR—HRAS—skin cancer	2.42e-05	0.000236	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling by GPCR—HRAS—skin cancer	2.42e-05	0.000236	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling by GPCR—KRAS—skin cancer	2.4e-05	0.000234	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—BRAF—skin cancer	2.37e-05	0.000232	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling by GPCR—KRAS—skin cancer	2.36e-05	0.000231	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—BRAF—skin cancer	2.34e-05	0.000228	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling by GPCR—IL6—skin cancer	2.31e-05	0.000226	CbGpPWpGaD
Yohimbine—DRD3—Signaling by GPCR—IL6—skin cancer	2.31e-05	0.000226	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—NRAS—skin cancer	2.28e-05	0.000223	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling by GPCR—NRAS—skin cancer	2.26e-05	0.000221	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—ERCC2—skin cancer	2.23e-05	0.000218	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—NRAS—skin cancer	2.23e-05	0.000218	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling by GPCR—HRAS—skin cancer	2.18e-05	0.000213	CbGpPWpGaD
Yohimbine—DRD2—Signaling by GPCR—KRAS—skin cancer	2.17e-05	0.000213	CbGpPWpGaD
Yohimbine—HTR2A—Signaling by GPCR—KRAS—skin cancer	2.14e-05	0.000209	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—BRAF—skin cancer	2.13e-05	0.000208	CbGpPWpGaD
Yohimbine—HTR1A—Signaling by GPCR—HRAS—skin cancer	2.11e-05	0.000206	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—NRAS—skin cancer	2.1e-05	0.000205	CbGpPWpGaD
Yohimbine—HTR2C—Signaling by GPCR—HRAS—skin cancer	2.09e-05	0.000205	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling by GPCR—IL6—skin cancer	2.09e-05	0.000204	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—PTGS2—skin cancer	2.05e-05	0.000201	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling by GPCR—HRAS—skin cancer	2.04e-05	0.000199	CbGpPWpGaD
Yohimbine—HTR1A—Signaling by GPCR—IL6—skin cancer	2.01e-05	0.000197	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling by GPCR—HRAS—skin cancer	2e-05	0.000196	CbGpPWpGaD
Yohimbine—HTR2C—Signaling by GPCR—IL6—skin cancer	2e-05	0.000196	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—KRAS—skin cancer	1.96e-05	0.000192	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—NRAS—skin cancer	1.95e-05	0.000191	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—NRAS—skin cancer	1.95e-05	0.000191	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling by GPCR—IL6—skin cancer	1.95e-05	0.000191	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling by GPCR—KRAS—skin cancer	1.95e-05	0.00019	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—KRAS—skin cancer	1.92e-05	0.000188	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling by GPCR—IL6—skin cancer	1.92e-05	0.000188	CbGpPWpGaD
Yohimbine—DRD2—Signaling by GPCR—HRAS—skin cancer	1.85e-05	0.000181	CbGpPWpGaD
Yohimbine—HTR2A—Signaling by GPCR—HRAS—skin cancer	1.82e-05	0.000178	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—KRAS—skin cancer	1.8e-05	0.000176	CbGpPWpGaD
Yohimbine—DRD2—Signaling by GPCR—IL6—skin cancer	1.77e-05	0.000173	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—NRAS—skin cancer	1.76e-05	0.000172	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—TP53—skin cancer	1.74e-05	0.00017	CbGpPWpGaD
Yohimbine—HTR2A—Signaling by GPCR—IL6—skin cancer	1.74e-05	0.00017	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—TP53—skin cancer	1.71e-05	0.000167	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—NRAS—skin cancer	1.7e-05	0.000166	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—NRAS—skin cancer	1.69e-05	0.000165	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—KRAS—skin cancer	1.68e-05	0.000164	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—KRAS—skin cancer	1.68e-05	0.000164	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—HRAS—skin cancer	1.67e-05	0.000163	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling by GPCR—HRAS—skin cancer	1.65e-05	0.000162	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—NRAS—skin cancer	1.64e-05	0.000161	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—HRAS—skin cancer	1.63e-05	0.00016	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—NRAS—skin cancer	1.62e-05	0.000158	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—TP53—skin cancer	1.6e-05	0.000157	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—IL6—skin cancer	1.6e-05	0.000156	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling by GPCR—IL6—skin cancer	1.58e-05	0.000155	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—IL6—skin cancer	1.56e-05	0.000153	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—HRAS—skin cancer	1.53e-05	0.00015	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—KRAS—skin cancer	1.52e-05	0.000148	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—NRAS—skin cancer	1.49e-05	0.000146	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—TP53—skin cancer	1.49e-05	0.000146	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—TP53—skin cancer	1.49e-05	0.000146	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—NRAS—skin cancer	1.47e-05	0.000144	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—IL6—skin cancer	1.47e-05	0.000144	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—KRAS—skin cancer	1.46e-05	0.000143	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—ERCC2—skin cancer	1.46e-05	0.000143	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—KRAS—skin cancer	1.46e-05	0.000142	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—HRAS—skin cancer	1.43e-05	0.00014	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—HRAS—skin cancer	1.43e-05	0.00014	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—KRAS—skin cancer	1.42e-05	0.000138	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—KRAS—skin cancer	1.39e-05	0.000136	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—IL6—skin cancer	1.37e-05	0.000134	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—IL6—skin cancer	1.37e-05	0.000134	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—TP53—skin cancer	1.35e-05	0.000132	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—PTGS2—skin cancer	1.34e-05	0.000131	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—NRAS—skin cancer	1.34e-05	0.000131	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—TP53—skin cancer	1.3e-05	0.000127	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—TP53—skin cancer	1.29e-05	0.000126	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—HRAS—skin cancer	1.29e-05	0.000126	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—KRAS—skin cancer	1.28e-05	0.000126	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—KRAS—skin cancer	1.26e-05	0.000124	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—TP53—skin cancer	1.26e-05	0.000123	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—HRAS—skin cancer	1.24e-05	0.000122	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—TP53—skin cancer	1.24e-05	0.000121	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—HRAS—skin cancer	1.24e-05	0.000121	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—IL6—skin cancer	1.23e-05	0.000121	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—HRAS—skin cancer	1.2e-05	0.000118	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—IL6—skin cancer	1.19e-05	0.000116	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—HRAS—skin cancer	1.18e-05	0.000116	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—IL6—skin cancer	1.18e-05	0.000116	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—IL6—skin cancer	1.15e-05	0.000113	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—KRAS—skin cancer	1.15e-05	0.000112	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—TP53—skin cancer	1.14e-05	0.000112	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—IL6—skin cancer	1.13e-05	0.000111	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—TP53—skin cancer	1.12e-05	0.00011	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—HRAS—skin cancer	1.09e-05	0.000107	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—HRAS—skin cancer	1.07e-05	0.000105	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—IL6—skin cancer	1.05e-05	0.000102	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—IL6—skin cancer	1.03e-05	0.000101	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—TP53—skin cancer	1.02e-05	9.99e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—HRAS—skin cancer	9.77e-06	9.56e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—IL6—skin cancer	9.35e-06	9.15e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—PTGS2—skin cancer	8.75e-06	8.56e-05	CbGpPWpGaD
